These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34122323)

  • 1. Stimulation of the Subthalamic Nucleus Changes Cortical-Subcortical Blood Flow Patterns During Speech: A Positron Emission Tomography Study.
    Sidtis JJ; Sidtis DVL; Dhawan V; Tagliati M; Eidelberg D
    Front Neurol; 2021; 12():684596. PubMed ID: 34122323
    [No Abstract]   [Full Text] [Related]  

  • 2. Subthalamic nucleus stimulation effects on single and combined task performance in Parkinson's disease patients: a PET study.
    Atkinson-Clement C; Maillet A; LeBars D; Lavenne F; Redouté J; Krainik A; Pollak P; Thobois S; Pinto S
    Brain Imaging Behav; 2017 Aug; 11(4):1139-1153. PubMed ID: 27704407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective network of deep brain stimulation of subthalamic nucleus with bimodal positron emission tomography/functional magnetic resonance imaging in Parkinson's disease.
    Chen HM; Sha ZQ; Ma HZ; He Y; Feng T
    CNS Neurosci Ther; 2018 Feb; 24(2):135-143. PubMed ID: 29222835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global and multi-focal changes in cerebral blood flow during subthalamic nucleus stimulation in Parkinson's disease.
    Mubeen AM; Ardekani B; Tagliati M; Alterman R; Dhawan V; Eidelberg D; Sidtis JJ
    J Cereb Blood Flow Metab; 2018 Apr; 38(4):697-705. PubMed ID: 28421851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved sensory gating of urinary bladder afferents in Parkinson's disease following subthalamic stimulation.
    Herzog J; Weiss PH; Assmus A; Wefer B; Seif C; Braun PM; Pinsker MO; Herzog H; Volkmann J; Deuschl G; Fink GR
    Brain; 2008 Jan; 131(Pt 1):132-45. PubMed ID: 17977862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of STN DBS on vesicular monoamine transporter 2 and glucose metabolism in Parkinson's disease.
    Smith GS; Mills KA; Pontone GM; Anderson WS; Perepezko KM; Brasic J; Zhou Y; Brandt J; Butson CR; Holt DP; Mathews WB; Dannals RF; Wong DF; Mari Z
    Parkinsonism Relat Disord; 2019 Jul; 64():235-241. PubMed ID: 31053531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential cognitive effects of unilateral left and right subthalamic nucleus deep brain stimulation for Parkinson disease.
    Del Bene VA; Martin RC; Brinkerhoff SA; Olson JW; Nelson MJ; Marotta D; Gonzalez CL; Mills KA; Kamath V; Bentley JN; Guthrie BL; Knight RT; Walker HC
    medRxiv; 2023 Mar; ():. PubMed ID: 36909562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation on gait kinematics in Parkinson's disease: a randomized, blinded study.
    Lizarraga KJ; Jagid JR; Luca CC
    J Neurol; 2016 Aug; 263(8):1652-6. PubMed ID: 27278062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Speech changes induced by deep brain stimulation of the subthalamic nucleus in Parkinson disease: involvement of the dentatorubrothalamic tract.
    Fenoy AJ; McHenry MA; Schiess MC
    J Neurosurg; 2017 Jun; 126(6):2017-2027. PubMed ID: 27611200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subthalamic deep brain stimulation aggravates speech problems in Parkinson's disease: Objective and subjective analysis of the influence of stimulation frequency and electrode contact location.
    Phokaewvarangkul O; Boonpang K; Bhidayasiri R
    Parkinsonism Relat Disord; 2019 Sep; 66():110-116. PubMed ID: 31327627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain networks underlying the clinical effects of long-term subthalamic stimulation for Parkinson's disease: a 4-year follow-up study with rCBF SPECT.
    Sestini S; Ramat S; Formiconi AR; Ammannati F; Sorbi S; Pupi A
    J Nucl Med; 2005 Sep; 46(9):1444-54. PubMed ID: 16157526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subthalamic nucleus stimulation and dysarthria in Parkinson's disease: a PET study.
    Pinto S; Thobois S; Costes N; Le Bars D; Benabid AL; Broussolle E; Pollak P; Gentil M
    Brain; 2004 Mar; 127(Pt 3):602-15. PubMed ID: 14736753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subthalamic nucleus stimulation improves Parkinsonian gait via brainstem locomotor centers.
    Weiss PH; Herzog J; Pötter-Nerger M; Falk D; Herzog H; Deuschl G; Volkmann J; Fink GR
    Mov Disord; 2015 Jul; 30(8):1121-5. PubMed ID: 25914247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chronic deep brain stimulation of the subthalamic nucleus for frontal lobe epilepsy: subtraction SPECT analysis.
    Shon YM; Lee KJ; Kim HJ; Chung YA; Ahn KJ; Kim YI; Yang DW; Kim BS
    Stereotact Funct Neurosurg; 2005; 83(2-3):84-90. PubMed ID: 16006780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subthalamic stimulation modulates cortical control of urinary bladder in Parkinson's disease.
    Herzog J; Weiss PH; Assmus A; Wefer B; Seif C; Braun PM; Herzog H; Volkmann J; Deuschl G; Fink GR
    Brain; 2006 Dec; 129(Pt 12):3366-75. PubMed ID: 17077105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Articulation Features of Parkinson's Disease Patients with Subthalamic Nucleus Deep Brain Stimulation.
    Tanaka Y; Tsuboi T; Watanabe H; Kajita Y; Nakatsubo D; Fujimoto Y; Ohdake R; Ito M; Atsuta N; Yamamoto M; Wakabayashi T; Katsuno M; Sobue G
    J Parkinsons Dis; 2016 Oct; 6(4):811-819. PubMed ID: 27662325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal Speech Change After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease Patients: A 2-Year Prospective Study.
    Tanaka Y; Tsuboi T; Watanabe H; Nakatsubo D; Maesawa S; Kato S; Kajita Y; Sato M; Oodake R; Hattori M; Yamamoto M; Wakabayashi T; Katsuno M; Sobue G
    J Parkinsons Dis; 2020; 10(1):131-140. PubMed ID: 31884493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Bilateral Subthalamic Nucleus Stimulation on Depressive Symptoms and Cerebral Glucose Metabolism in Parkinson's Disease: A
    Zhang X; Zhang H; Lin Z; Barbosa DAN; Lai Y; Halpern CH; Voon V; Li D; Zhang C; Sun B
    Front Neurosci; 2022; 16():843667. PubMed ID: 35720690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Speech outcomes in Parkinson's disease after subthalamic nucleus deep brain stimulation: A systematic review.
    Aldridge D; Theodoros D; Angwin A; Vogel AP
    Parkinsonism Relat Disord; 2016 Dec; 33():3-11. PubMed ID: 27693195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Speech Intelligibility During Clinical and Low Frequency.
    Sidtis JJ; Sidtis DVL; Ramdhani R; Tagliati M
    Brain Sci; 2020 Jan; 10(1):. PubMed ID: 31906549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.